Annual Report

Overview

The report describes Antibiotice's expansion of its pharmaceutical portfolio in 2010, including 13 new marketing authorizations and entry into the U.S. market with injectable Ampicillin. Net turnover reached 243.6 million LEI. The company also reported environmental management measures and no environmental incidents, while continuing community initiatives such as donations and scholarships.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2010
Period: Ends 31 December 2010
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services